New eye scans could predict vision and brain problems in preterm babies

NCT ID NCT04995341

Recruiting now Knowledge-focused Sponsor: Duke University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows preterm infants who were part of an earlier study to see if a new, portable eye imaging device can detect hidden signs of retinopathy of prematurity (ROP), a vision-threatening condition. Researchers will compare the new imaging to standard photos and track children's vision and brain development up to age 5. The goal is to find early clues that predict which babies need treatment or may have future learning or vision issues.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better early detection and treatment of eye problems in preterm babies, potentially improving their vision and brain development.
What could go wrong: This is an observational study, not a treatment trial. It may not directly change care, and results may take years to translate into practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINOPATHY OF PREMATURITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

retinopathy of prematurity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RETINOPATHY OF PREMATURITY

Contacts and locations

Locations

Duke University Eye Center
RECRUITING

Durham, North Carolina, 27705, United States
University of Pennsylvania, Center for Preventive Ophthalmology and Biostatistics
NOT_YET_RECRUITING

Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.